2008 Global Conference: Financing Medical Innovation

Description
Funding for biomedical research and development has fallen off in recent years. Large pharmaceutical companies have watched their stock values drop and their business models crumble, and they’re shying away from risky early-stage drug discovery and development. Research and development output, as measured by FDA applications for approval to initiate clinical trials and market new drugs, has plummeted. Unfortunately, the need for new treatments hasn’t diminished. So what do we do about the acute shortage of investment capital that’s being felt from drug and device discovery all the way through clinical trials? Can financial technology help? The 2008 Milken Institute Global Conference set out to tackle these issues in a riveting discussion you won’t want to miss.

This product is manufactured on demand using DVD-R recordable media. Amazon.com’s standard return policy will apply.
2008 Global Conference: Financing Medical Innovation